Download PDF

1. Company Snapshot

1.a. Company Description

COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania.It offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, and characterizations; and endodontics products, such as posts, rotary and hand files, irrigation solutions, obturation and sealing materials, Gutta-percha and paper points, endo engines, apex locators, and endo accessories.The company also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consisting of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams and dam kits, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verification products.


In addition, it offers infection control products, which include ultrasonic cleaning units, patient bibs, headrest covers, and sterile covers; rotary instruments, such as diamond and carbide burs, polishers, kits, and accessories; and laboratory products comprising gingiva masks, lab putty products, model making products, waxes, occlusion control products, accessories, HP burs, and silicone polishers.The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008.COLTENE Holding AG was incorporated in 2005 and is headquartered in Altstätten, Switzerland.

Show Full description

1.b. Last Insights on CLTN

COLTENE Holding AG's recent performance was driven by a robust earnings release, with the company reporting a significant increase in revenue and profitability. The company's strong financials were underpinned by its diversified product portfolio, which includes dental materials and equipment. Furthermore, COLTENE's significant control by private companies implies a high level of strategic direction and decision-making, potentially leading to more focused and effective business operations. Additionally, the company's substantial cash reserves and absence of debt provide a solid foundation for future growth and investment opportunities.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

COLTENE Holding AG (VTX:CLTN) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dec -03

Source:

Card image cap

Is Now The Time To Look At Buying COLTENE Holding AG (VTX:CLTN)?

Nov -06

Source:

Card image cap

Declining Stock and Decent Financials: Is The Market Wrong About COLTENE Holding AG (VTX:CLTN)?

Sep -15

Source:

Card image cap

While individual investors own 31% of COLTENE Holding AG (VTX:CLTN), private companies are its largest shareholders with 35% ownership

Jul -20

Source:

Card image cap

APG|SGA (VTX:APGN) Has Some Difficulty Using Its Capital Effectively

Jun -18

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (2.40%)

6. Segments

Efficient Treatment

Expected Growth: 2%

COLTENE Holding AG's 2% growth is driven by increasing demand for efficient dental treatment solutions, expansion into emerging markets, and strategic partnerships. Additionally, the company's focus on innovation, digitalization, and sustainability contributes to its growth. Furthermore, the rising awareness of oral health and the need for preventive care also support the growth of COLTENE's efficient treatment segment.

Infection Control

Expected Growth: 4%

Strong demand for infection control products driven by increasing awareness of healthcare-associated infections, growing importance of patient safety, and rising regulatory requirements. Additionally, COLTENE's innovative product portfolio, strategic partnerships, and expanding global presence contribute to the segment's growth.

Dental Preservation

Expected Growth: 1%

Dental Preservation's 1% growth driven by increasing demand for preventive dentistry, rising awareness of oral health, and COLTENE's innovative products such as filling materials and endodontic solutions, catering to the growing need for minimally invasive treatments.

7. Detailed Products

Dental Consumables

COLTENE Holding AG offers a wide range of dental consumables, including impression materials, dental cements, and dental anesthetics.

Dental Equipment

The company provides a variety of dental equipment, such as dental chairs, dental units, and dental lights.

Digital Dentistry

COLTENE Holding AG offers digital dentistry solutions, including intraoral scanners, CAD/CAM systems, and dental software.

Dental Laboratory Products

The company provides a range of dental laboratory products, including dental ceramics, composites, and impression materials.

Endodontic Solutions

COLTENE Holding AG offers a range of endodontic solutions, including root canal files, obturators, and sealers.

8. COLTENE Holding AG's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for COLTENE Holding AG is moderate, as there are alternative products available in the market, but they are not highly attractive to customers.

Bargaining Power Of Customers

The bargaining power of customers for COLTENE Holding AG is low, as customers have limited options and the company has a strong brand presence.

Bargaining Power Of Suppliers

The bargaining power of suppliers for COLTENE Holding AG is moderate, as the company relies on a few key suppliers, but has some flexibility in its supply chain.

Threat Of New Entrants

The threat of new entrants for COLTENE Holding AG is high, as the dental industry is attractive and there are low barriers to entry.

Intensity Of Rivalry

The intensity of rivalry for COLTENE Holding AG is high, as the dental industry is highly competitive and there are many established players.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 31.72%
Debt Cost 3.95%
Equity Weight 68.28%
Equity Cost 8.73%
WACC 7.21%
Leverage 46.45%

11. Quality Control: COLTENE Holding AG passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Coltene

A-Score: 4.7/10

Value: 3.9

Growth: 2.7

Quality: 5.6

Yield: 8.1

Momentum: 2.0

Volatility: 5.7

1-Year Total Return ->

View Full Report
Stock-Card
Safilo

A-Score: 4.6/10

Value: 6.9

Growth: 3.7

Quality: 6.3

Yield: 0.0

Momentum: 8.5

Volatility: 2.0

1-Year Total Return ->

View Full Report
Stock-Card
Advanced Medical Solutions

A-Score: 3.8/10

Value: 3.0

Growth: 3.9

Quality: 5.2

Yield: 1.2

Momentum: 6.0

Volatility: 3.3

1-Year Total Return ->

View Full Report
Stock-Card
SKAN

A-Score: 3.6/10

Value: 0.6

Growth: 7.8

Quality: 5.8

Yield: 0.6

Momentum: 1.0

Volatility: 6.0

1-Year Total Return ->

View Full Report
Stock-Card
Biotage

A-Score: 3.4/10

Value: 1.3

Growth: 6.3

Quality: 7.0

Yield: 1.2

Momentum: 1.0

Volatility: 3.7

1-Year Total Return ->

View Full Report
Stock-Card
Tobii Dynavox

A-Score: 2.6/10

Value: 0.2

Growth: 5.2

Quality: 4.2

Yield: 0.0

Momentum: 4.0

Volatility: 2.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

52.1$

Current Price

52.1$

Potential

-0.00%

Expected Cash-Flows